Bayesian Optimization of DBS for Gait
Part of paid clinical trials in Minneapolis, Minnesota.
- Sponsor
- University of Minnesota
- Study ID
- NCT07835308
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Parkinson Disease (PD)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Deep Brain Stimulation — OTHERDBS within FDA-approved limits and labeling for symptoms of PD
Study Details
This project aims to establish the feasibility of Bayesian optimization for tuning deep brain stimulation (DBS) to treat gait symptoms in Parkinson's disease (PD) patients. Our primary question is: Can Bayesian optimization of DBS achieve reproducible results within a feasible number of gait measurements? PD patients will be enrolled who have DBS of the subthalamic nucleus (STN) or globus pallidus (GP) in whom at least 3 months have passed since activation of their neurostimulators, for stabilization of clinical stimulator settings. We will apply Bayesian optimization to derive DBS settings which maximally lengthen step length relative to the OFF DBS state.
Key Dates
- First listed
- Sep 22, 2026
- Start date
- Sep 30, 2026
- Status verified
- Sep 2026
- Primary completion
- Mar 31, 2031
- Completion
- Mar 31, 2033
Study Design
- Enrollment
- 15 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: All participantsAll participants will be allocated to this group for DBS stimulation within FDA-approved limits and labeling for symptoms of PD.
Primary Outcome Measure
Gait Test [ Time Frame: This will be repeated approximately 30 times throughout the study visit (Day 1) on various DBS settings to reach putatively optimal DBS settings. ]
Central Contacts
- Johanna Caskey, BA763-353-9470
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Minnesota | Minneapolis | Minnesota | 55455 | Scott Cooper, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Minneapolis, MN
Related Studies
- GBPDC: Gut-Brain in PD Consortium Master ProtocolRecruiting · Duke University · Stanford, California
- Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy VolunteersPHASE1/PHASE2 · Recruiting · Ashvattha Therapeutics, Inc. · San Francisco, California
- Robotic Apparel to Prevent Freezing of Gait in Parkinson DiseaseRecruiting · Harvard Medical School (HMS and HSDM) · Allston, Massachusetts
- Behavioral Intervention for Lifestyle Physical Activity in Parkinson's DiseaseNot Yet Recruiting · University of Illinois at Chicago · Chicago, Illinois